BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UW Diabetes Institute - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://uwmdi.org
X-WR-CALDESC:Events for UW Diabetes Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230202T080000
DTEND;TZID=UTC:20230202T090000
DTSTAMP:20260415T061814
CREATED:20230127T182118Z
LAST-MODIFIED:20230127T182118Z
UID:6626-1675324800-1675328400@uwmdi.org
SUMMARY:Jeffrey Millman\, PhD: A New Era of Diabetes Treatment: The Use of  Human Pluripotent Stem Cell-Derived Islets
DESCRIPTION:Dr. Jeffrey Millman is  an Associate Professor of Medicine and Biomedical Engineering at Washington University School of Medicine. He received his Ph.D. from MIT and completed his postdoctoral training in the laboratory of Dr. Douglas Melton at Harvard University. His current research is focused on synergizing both biomedical engineering and cell biology approaches to use stem cells for the study and treatment of diabetes. He is developing new approaches for the differentiation of insulin-producing islets from stem cells and improving their utility for cell replacement therapy and in vitro disease models. His innovations have been licensed to several biotechnology and startup companies in the diabetes space and resulted in one ongoing clinical trial. His laboratory is supported by the NIH NIDDK and JDRF\, and his scholarship has been recently recognized by awards from the JDRF\, American Institute of Chemical Engineering\, and the Biomedical Engineering Society. \nJeffrey Millman\, PhD \nAssociate Professor of Medicine\nDivision of Endocrinology\, Metabolism\, and Lipid Research\nAffiliate Faculty\, Department of Biomedical Engineering\nWashington University School of Medicine \nView Event Flyer
URL:https://uwmdi.org/event/jeffrey-millman-phd-a-new-era-of-diabetes-treatment-the-use-of-human-pluripotent-stem-cell-derived-islets/
END:VEVENT
END:VCALENDAR